Abstract
Purpose To evaluate the impact of human papillomavirus (HPV) vaccine availability on uptake among 19- to 26-year-old female patients of Planned Parenthood of Mid and South Michigan before and after the vaccine became available at the health centers. Results Availability of the HPV vaccine increased vaccine uptake from 11% before clinic availability to 16% after availability. Accessibility, including cost and provider recommendation, may have influenced uptake. Implications Improving availability of the HPV vaccine, while helpful, is not sufficient for a substantial increase in uptake. Issues of accessibility, including cost and provider recommendation, must also be addressed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
